CME Group Quarterly Income Statement
NASDAQ: CMEFinanceInvestment Bankers/Brokers/ServiceUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CME Group revenue and earnings
In the quarter ended Jun 30, 2026, CME Group generated $1.71 billion in revenue, up 0.8% from the same quarter a year earlier. Net income was $1.04 billion (+1.6% year over year), for a net margin of 61.1% versus a median of 60.6% in the prior 5 quarters. Operating margin was 64.9%.
Diluted earnings per share came in at $2.88, up from $2.81.
Summary generated from market data by MetaCap's automated system. Methodology
CME Group income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.71B | 1.88B | 1.65B | 1.54B | 1.69B | 1.64B | 1.53B | 1.58B | 1.53B | 1.49B | 1.44B | 1.34B |
| Revenue growth (YoY) | +0.84% | +14.48% | +8.09% | -2.95% | +10.41% | +10.38% | +5.98% | +18.43% | +12.67% | +3.21% | +19.17% | +8.96% |
| Operating Income | 1.11B | 1.31B | 1.02B | 972.60M | 1.13B | 1.11B | 947.10M | 1.02B | 1.00B | 959.60M | 863.20M | 820.20M |
| Interest Expense | 43.60M | 43.60M | 43.70M | 44.00M | 44.00M | 41.70M | 40.70M | 40.20M | 40.10M | 39.90M | 39.70M | 39.60M |
| Other Income (Expense) | 220.60M | 201.20M | 558.80M | 204.40M | 201.00M | 136.80M | 149.50M | 152.70M | 153.90M | 153.80M | 142.80M | 154.10M |
| Pretax Income | 1.33B | 1.51B | 1.58B | 1.18B | 1.33B | 1.24B | 1.10B | 1.18B | 1.15B | 1.11B | 1.01B | 974.30M |
| Income Tax | 285.90M | 356.60M | 395.50M | 269.00M | 305.20M | 288.60M | 222.00M | 264.10M | 271.30M | 258.20M | 191.40M | 224.10M |
| Net Income | 1.04B | 1.15B | 1.18B | 908.00M | 1.03B | 956.20M | 874.60M | 912.80M | 883.20M | 855.20M | 814.60M | 750.20M |
| Net Income growth (YoY) | +1.63% | +20.72% | +35.25% | -0.53% | +16.07% | +11.81% | +7.37% | +21.67% | +13.58% | -3.24% | +27.70% | +10.39% |
| EPS (Basic) | 2.89 | 3.25 | 3.25 | 2.49 | 2.81 | 2.63 | 2.40 | 2.51 | 2.43 | 2.35 | 2.24 | 2.06 |
| EPS (Diluted) | 2.88 | 3.18 | 3.24 | 2.49 | 2.81 | 2.62 | 2.40 | 2.50 | 2.42 | 2.35 | 2.23 | 2.06 |
| Shares Outstanding (Basic) | 360.68M | 359.32M | — | 359.69M | 359.66M | 359.61M | — | 359.40M | 359.33M | 359.26M | — | 359.02M |
| Shares Outstanding (Diluted) | 361.28M | 363.21M | — | 360.42M | 360.36M | 360.23M | — | 359.99M | 359.87M | 359.83M | — | 359.62M |
| EBITDA | 1.14B | 1.34B | — | 999.00M | 1.16B | 1.14B | — | 1.05B | 1.03B | 989.70M | — | 851.30M |
| Operating Margin | 64.89% | 69.66% | 61.84% | 63.25% | 66.74% | 67.47% | 62.09% | 64.64% | 65.29% | 64.49% | 59.97% | 61.31% |
| Net Margin | 61.06% | 61.40% | 71.75% | 59.05% | 60.59% | 58.22% | 57.34% | 57.61% | 57.63% | 57.48% | 56.60% | 56.08% |
This table shows 12 quarterly periods of CME Group's income statement, from Q2 2026 back to Q3 2023, across 14 line items including revenue, operating income, interest expense. Values in USD; B = billions, M = millions. Fiscal periods follow CME's reporting calendar. What is a income statement?